BioLife Solutions Inc. (BLFS)
undefined
undefined%
At close: undefined
26.70
0.11%
After-hours Dec 13, 2024, 04:00 PM EST

Company Description

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally.

The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.

It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials.

The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services.

It markets and sells its products directly, as well as through third party distributors.

BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.

BioLife Solutions Inc.
BioLife Solutions Inc. logo
Country United States
IPO Date Nov 22, 1989
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 409
CEO Roderick de Greef

Contact Details

Address:
3303 Monte Villa Parkway
Bothell, Washington
United States
Website https://www.biolifesolutions.com

Stock Details

Ticker Symbol BLFS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000834365
CUSIP Number 09062W204
ISIN Number US09062W2044
Employer ID 94-3076866
SIC Code 3845

Key Executives

Name Position
Roderick de Greef Chief Executive Officer & Chairman
Sean Werner Ph.D. Chief Technology Officer
Troy Wichterman CPA Chief Financial Officer
Dr. Aby J. Mathew Ph.D. Chairman of Scientific Advisory Board, Executive Vice President & Chief Scientific Officer
Karen Foster Chief Quality & Operations Officer
Sarah Aebersold J.D. Chief Human Resources Officer
Todd Berard Chief Commercial Officer

Latest SEC Filings

Date Type Title
Dec 06, 2024 3 Filing
Nov 29, 2024 4 Filing
Nov 29, 2024 4 Filing
Nov 29, 2024 4 Filing
Nov 29, 2024 4 Filing
Nov 29, 2024 4 Filing
Nov 20, 2024 8-K Current Report
Nov 19, 2024 4 Filing
Nov 14, 2024 4 Filing
Nov 14, 2024 4 Filing